CBRE three-lens brief
Evidence-based stock research on CBRE. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 8.9pp over 30 days.
- Outperforming SPY by 8.9pp over 30 days.
- Analyst mean target $176.33 — 24% above current (12 analysts).
- Earnings scheduled 2026-07-29.
CBRE closed at $142.22 (+0.82%) as of 2026-07-10. Market cap: $41.64B. P/E (trailing) 32.2. Price is above the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 8.9pp over 30 days.; analyst mean target $176.33 — 24% above current (12 analysts).. Last quarter: Revenue $10.53B, net income $318.00M, free cash flow $1.09B. Watching for: 2026-07-29 earnings release (18 days out).
Why three lenses on CBRE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CBREacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CBRE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CBRE brief"></iframe>